Covered recipient · General Payments record
EDUARDO GONZALEZ HERNANDEZ
General Payments · PY2018–2024
$7,029.69
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $406.12 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Shoulder Innovations, Inc. | $149.33 | 2 |
| Anika Therapeutics, Inc. | $113.50 | 1 |
| ACUMED LLC | $64.21 | 2 |
| Amgen Inc. | $39.49 | 2 |
| Endo Pharmaceuticals Inc. | $22.50 | 1 |
| Pacira Pharmaceuticals Incorporated | $17.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACUMED LLC | $14.21 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125025619 | CMS |
| ACUMED LLC | $50.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125025628 | CMS |
| Amgen Inc. | $18.42 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586828 | CMS |
| Amgen Inc. | $21.07 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586830 | CMS |
| Anika Therapeutics, Inc. | $113.50 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136023517 | CMS |
| Endo Pharmaceuticals Inc. | $22.50 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137014402 | CMS |
| Pacira Pharmaceuticals Incorporated | $17.09 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151244332 | CMS |
| Shoulder Innovations, Inc. | $77.52 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154014029 | CMS |
| Shoulder Innovations, Inc. | $71.81 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154014031 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.